Integrative transcriptome-based drug repurposing in tuberculosis
This study presents a robust computational workflow that integrates diverse tuberculosis transcriptomic signatures with multiple connectivity scoring methods to systematically identify 64 FDA-approved drugs as promising host-directed therapeutics and 12 novel bridging genes for future experimental validation.